01/20/2014 | Mark Hillen
The pupil of the eye is dark, and the cornea highly reflective – it acts as a mirror. Combine this with high resolution photography, and you get a whole new vista.
The media have been building up “eyeball jewelry” as a potential craze, but the evidence suggests otherwise
Gene therapy for ocular disease will soon be available. Stem cell therapies too. They may be able to cure the currently untreatable, but at what price? And will anyone pay it?
12/04/2013
Expert opinion: infection prevention & treatment in photorefractive surgery patients.
Jim discusses his background, leadership style and his vision for Oraya's future with us.
12/04/2013 | Sophia Ktori
Patients need to know what their ophthalmologist actually ‘does’, and what to expect when they are referred.
12/04/2013 | Kristine Morrill
Market research requires that you examine three things: customers, the competition and the environment.
12/03/2013 | Irv Arons, Mark Hillen
Therapies based on stem cell treatments are considered to have tremendous potential in medicine.
12/02/2013 | Richard Gallagher
Five questions that must be answered on the causes and consequences of near-sightedness.
12/02/2013 | Mark Hillen
Yet more ophthalmology acquisitions and licensing deals were announced this month
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: